Expertise in
6
conditions

Maura Nicolosi

Citta, IT 
Expertise in
6
conditions
Citta, IT 

Overview

Maura Nicolosi practices practicing medicine in Citta, Italy.

Ms. Nicolosi is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera, Non-Hodgkin Lymphoma, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 43 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Citta, Italy
Other Locations
Turin, 10126, Italy
Novara, Italy
Florence, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

The Benefit/Risk Profile of Pegylated Proline-Interferon Alpha-2b (AOP2014) Added to the Best Available Strategy Based on Phlebotomies in Low-risk Patients With Polycythemia Vera (PV). The Low-PV Randomized Trial
The Benefit/Risk Profile of Pegylated Proline-Interferon Alpha-2b (AOP2014) Added to the Best Available Strategy Based on Phlebotomies in Low-risk Patients With Polycythemia Vera (PV). The Low-PV Randomized Trial
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Procedure
Study Drugs: AOP2014, Acetylsalicylic acid
Study Phase: Phase 2

43 Total Publications

Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).
Real-life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy-cell leukemia: A multicenter Italian retrospective study (HCL-PG03R).
Journal: HemaSphere
Published: September 08, 2025

Frequently Asked Questions about Maura Nicolosi

Is Maura Nicolosi a top-rated expert for Myelofibrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Maura Nicolosi is classified as an Distinguished expert for Myelofibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Maura Nicolosi participate in research or clinical trials?

Yes. Maura Nicolosi has published 43 articles and abstracts on conditions like Myelofibrosis. You can view a list of Maura Nicolosi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Nicolosi's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile